Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

134 North e nurse

12th World AIDS Conference

-Keyword

Abstract -

SKeyword

Abstract

g point"/Facing AIDS in Uganda: Our experience with the "m
/When worlds collide - meets South: AIDS on the United St
ry results from 8 cases, America, 1995-1997/HIV seronega
children in Chandigarh, India: Their knowledge and attitude t
nd behavior of CSWs in Chennai/Knowledge, attitude, pract
among individuals from African attending a HIV reference ce
HIV infection in Belem, Brazil/Prevalence of HTLV 1 and 11
and second-generation African immigrants/Conducts logics
tending a STD clinic in north eastern state of India/A study on sex
oach carried out at two Buenos Aires neighborhood hospital
smission of HIV-1 in the of Portugal/Vertical transmission of
TDs among truckers on Indian highways/Prevention of HIV/
n of Galicia (Spain) and region of Portugal/HIV/AIDS in the fi
Galicia (Spain) and the region of Portugal/Evaluation of an i
supporting program in a northeast province, Thailand/Community
1 and HTLV infection in Brazil: Differences for male and
ttending sauna clubs in Italy/Sexual behavior among g
cs in Fortaleza, Ceara, Brazil/Profile of the women with
ntion to HIV/AIDS in the of Brazil/Sex workers: An exper
volving fund program in Brazil/A condom revolving fund
against AIDS in Ceara, Brazil/Street theater against Al
HIV/AIDS prevention in of Brazil/Sexual workers capabi
f HIV transmission in northeastern Brazil/The role of cultural an
s in a megacity from the of Brazil/Sexual behaviour
rban community in the United States/HIV not asso
affected by HIV/AIDS in northern Thailand/Mapping resources av

d female sex workers in
e HIV epidemic among
g male blood donors in
earing women in upper
d counselling clinics in
g injecting drug users in
vaginal microbicides in
V discordant couples in
Id in a remote district of
e in an HIV epicenter in
s in an HIV epicenter in
I-infant transmission in
g women in Japan and
I transmission of HIV in
rcial sex workers in the
a remote rural district of
isease department in
women and children in
ani and Moyo Districts,
d their male partners in
r HIV-1 vaccine trials in
a intervention project in
hnic minorities living in
ng Arabian prisoners of
DS and their families in
onses to HIV/AIDS in a
ed rural adolescence in
f female sex workers in
es in Adjumani District,
V-discordant couples in
fection in young men in
ion in refugee camps in
ng exchanges between
/Care of widows in the
rt programme in the six
ection among women in

Thailand/Disease progression a
Thai men/The role of same-sex
Thailand from 1990 to 1996/Dec
Thailand/Declining seroprevale
Thailand, 1995-1997/HIV and s
Italy, 1990-1996 (NISDA study)/
Thailand/Perception of HIV tran
Thailand/Factors influencing ma
Uganda/Free condoms/sold con
Thailand, 1989-1997/Increasin
Thailand, 1989-1997/Trend of H
Thailand/Neutralizing antibody,
Thailand/Comparison of knowle
Thailand/Viral load and male to f
provinces of Vietnam: Social bac
Uganda/My experience as an HI
Italy/Two-year survey (1996-97
Thailand/When community-bas
Uganda/Why do people not use
California diminishes over time/
Thailand; the Thai HIVNET/WRA
Tanzania/Community based HI
Thailand to develop their own ind
Italy using peer education metho
Thailand/Community acceptanc
Thai HIV epicenter/Evolution of
Uganda/The experience of parti
Thailand/Leaving sex work: Wor
Uganda/AIDS prevention knowl
California is influenced by serost
Thailand, 1991-1997, increasin
Uganda/Vulnerability of refugee
activists and southern HIV+ peo
region of Malawi by Patricia C. A
provinces/Assessment of the Th
Thailand/Knowledge on matern

34254
34369
42103
60041
60071
60257
60745
60943
22201
23159
23316
33374
60190
60213
13421
23231
23426
23498
33376
33429
33461
43349
14239
14311
60415
12420
13135
13136
13139
13143
13152
13185
14156
14169
466*/14263
452*/22131
583*/23198
23290
23320
23388
24161
24301
32261
32414
33120
33126
33212
33423
33527
33560
34167
72*/42398
43181
43257
43339
43428
517*/43555
44209
44291
60031
60165
60768
23152
11196
23136
22102
42463
60266
60438
14168
14298
14306
43124
43216

43556
44187
44248
60364
12370
22372

ndia/Unique and highly HIV-1 strains in HIV-1 + HIV-2 co-inf
st JE-2147 (KNI-764), a inhibitor of HIV-1 protease/Anti-HIV
ned by a rigid spacer: A series of dimerization HIV-1 proteas
2 study of amprenavir, a protease inhibitor, in combination wit
dioxolane guanosine a inhibitor of HIV-1 replication/(-)-/3 -type A, subtype B, and A/B recombinant/Genetic characteri
ng immunization with a HIV-1 V3 recombinant multi-epitope
IDS booths (MABs) - A intervention for migrating labour and
e first phase I study of a vaginal microbicide/BufferGel: Res
ctivity of AMD3465, a antagonist of the CXCR4 receptor/A
nfection/Application of "detuned" HIV EIA to qualify and mo
d oral bioavailability of a HIV protease inhibitor JE-2147 (KNI
HIV seroprevalence/A HIV tracking system for an inner-city
d test interpretation?/A method to define appropriateness of
ethyl-tetrahydrofuran, a guanine phosphonate analogue/Ant
olecular evidence for a Mycobacterium causing disseminat
diseases/Detection by nPCR of Treponema pallidum DNA in cere
of lamivudine to current NRTI therapy in HIV infected children - Th
nucleoside analogue ( ) therapy at 24 weeks [Study DMP 26
ZT/ddC to other double combinations/Virological response i
sitivity and confers little cross resistance/3TC resistance is a
finavir mesylate) with 2 's/Safety and efficacy of BID dosing o
ranscriptase inhibitors ( NRTIs) in HIV-infected children/Saquinavi
ranscriptase inhibitors ( ) in HIV infected patients/Indinavir (
onavir + saquinavir + 2 as first line HAART therapy: 21 pati
ce of 11 years of care in Nsambya Hospital/Integrated AIDS care p
of co-receptors used by NSI HIV-1 strains that infect CD4+ T-cell lin
chemokine production/ and not SI viruses enhance cell prolifer
europsychologic tests ( NT ) as markers of early neurological deficit
erculous mycobacteria ( NTM ) in HIV disease/Liposomal amikacin (
al HIV Prevention Trial ( NTPHPT): Design and study update/North
r mechanisms of HIV-1 nuclear import: matrix antigen and Vpr are
ompounds that inhibit localization of HIV-1 genome/Nov
age of vimentin and the mitotic apparatus (NuMA) protein
uneT) on the control of factor kappa-B activation and cyto
tive assays using the 5' nuclease technology/Development of qua
ductions of sub-cortical nuclei in HIV+ subjects are correlated with
munity/Improvement of nucleic acid vaccination against HIV-1 tow
nfection/Mycobacterial acids in tissues of patients with HI
of interactions between nucleocapsid protein, viral RNA and prote
eting anti-HIV agents to protein zinc knuckles witho
ay to quantify the HIV-1 protein p7/An electrochemi
ne (NVP)+3TC+ZDV in nucleoside-experienced patients: An ope
dovudine and a second nucleoside analog during pregnancy/Co
y HIV infection/Double analog therapy in patients with
n combination with new analogs in nucleoside experie
se sparing" nevirapine/ (NVP/nuc) combination therap
GC) + nelfinavir (NFV) + reverse transcriptase inhibitor
ft gelatin capsules plus antiretroviral agents in HIV-inf
s in combination with 2 s or nelfinavir (NFV) plus 1 nucl
lus saquinavir, with two analogues/Efficacy and safet
n combination with two reverse transcriptase inhibitor
ted patients receiving analogue (NRTI) therapy at 24
oviral therapy naive or analogue experienced HIV-1 i
ith ritonavir and double inhibitor therapy/Durable sup
esistance to antiviral inhibitors in short-time pretreat
ssay in the detection of analogue resistance in a HIV-i
Enhanced activation of analogues in the presence of h
/A randomized study of regimens in antiretroviral (AR
7)/Combination of two analogues as initial antiretrovir
e to saquinavir plus two analogues in the treatment HI
w-up of a cohort of 144 nucleosides-experienced patients treate
n combination with two nucleosides in treatment-naive HIV-1-ser
s in combination with 2 or nelfinavir (NFV) plus 1 nuc
iomeric oxaselenolane /Synthesis, chiral separation
/Cell tropism, subtype, nucleotide diversity and drug resistance of
s of viral properties and sequence of HIV from patients
exuality in Brasilia/The nucleus of health and sexuality in Brasilia/
1 Amplicor Monitor and NucliSens quantitative HIV-1 RNA PCR a
titation/Comparison of and Roche Monitor assays for
A ultrasensitive assay ( Nuclisens ) for quantifying HIV-1 plasma vi
IV RNA assay and the nuclisens for quantitation of HIV-1 RNA in
ear mitotic apparatus ( NuMA ) protein by HIV-1 protease may play
dren with HIV infection/ Nurse 's experiences caring for children wit
ment to data collection/ assessment in an AIDS hospital day

uberculosis (TB) liaison nurse in the HIV clinic/HIV/tuberculosis (T
a C. Amadi community for St. John's Hospital in Malawi/Ca
ontinuing education for 's team on day care unit in Brazil, thr

utation detection assay/ clinical applications of the LiPA HIV- 41223
bits CCR5 recycling - A novel inhibitory mechanism of HIV infectivi 58*/11102

11165
12270
12289
12321
12358
13194
21215
242*/23343
33158
41183
42118
42273
43429
43529
60291
60412
22101
12249
22343
32281
32299
60631
12248
12350
60619
34326
11111
21175
32218
22170
12250
381*/11144
12370
21150
21212
42160
32215
21205
41157
379*/11131
41187
42129
12369
463*/12152
12198
125*/12203
12231
12248
12260
12314
12336
12350
22343
22386
22395
233*/32282
41220
42262
60397
60411
60671
60875
12145
12314
41200
60171
60586
13578
41127
42162
60679
41128
21150
22457
60183

61*/13247
60031
60182

ers and their spouses in northwest Tanzania/HIV incidence and H
idemiological cluster in Norway /A unique recombinant HIV-1, mixi
mong young gay men in /Factors influencing sexual risk ta
excess of hospital stay/ Nosocomial bloodstream infections in HIV
n an Brazilian hospital/ infections (NI) in HIV infected
n year period/Study of nosocomial outbreak of HIV-1 infection in
S patients/Incidence of infections in HIV infected/AID
ncing HIV/AIDS partner notification /Factors influencing HIV/AIDS

nts: Outcome of partner
Nairobi-Kenya/Partner
HIV-infected clients by
sting, reporting, partner
e to re-examine partner
vention policy: Spousal
effectiveness of partner
azards in HIV partner
ation of HIV-1 genome/ Novel
Results from first study/

- European Concerted Action
by clients with sexually trans
assistance program field staff,and confidentiality: An end to
for HIV exposure/Now is the ti
requirements in the United St
and counselling and testing: A
/Expecting the unexpected: Id
anti-retroviral compounds that inhibi
double protease combinations-com